Oral SARS-CoV-2 host responses predict the early COVID-19 disease course

被引:0
|
作者
Seaman, William T. [1 ,2 ]
Keener, Olive [2 ,3 ]
Nanayakkara, Dinelka [4 ]
Mollan, Katie R. [5 ,6 ]
Premkumar, Lakshmanane [7 ]
Cuadra, Edwing Centeno [7 ]
Jones, Corbin D. [5 ,8 ]
Pettifor, Audrey [5 ,6 ]
Bowman, Natalie M. [5 ]
Wang, Frank [9 ]
Webster-Cyriaque, Jennifer [1 ,2 ,5 ,10 ]
机构
[1] Natl Inst Allergy & Infect Dis, NIH, Bethesda, MD 20892 USA
[2] Univ N Carolina, Div Oral & Craniofacial Hlth Sci, Chapel Hill, NC 27599 USA
[3] North Carolina Sch Math & Sci, Durham, NC USA
[4] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA
[5] Univ N Carolina, UNC Sch Med, 111 Mason Farm Rd,Med Biomol Res Bldg,Room 2341b, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
[7] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA
[8] Univ N Carolina, Dept Biol, Chapel Hill, NC USA
[9] Biomedomics Inc, Morrisville, NC USA
[10] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
基金
美国国家卫生研究院;
关键词
D O I
10.1038/s41598-024-67504-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oral fluids provide ready detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and host responses. This study sought to evaluate relationships between oral virus, oral and systemic anti-SARS-CoV-2-specific antibodies, and symptoms. Oral fluids (saliva/throat wash (saliva/TW)) and serum were collected from asymptomatic and symptomatic, nasopharyngeal (NP) SARS-CoV-2 RT-qPCR+ human participants (n = 45). SARS-CoV-2 RT-qPCR and N-antigen detection by immunoblot and lateral flow assay (LFA) were performed. RT-qPCR for subgenomic RNA (sgRNA) was sequence confirmed. SARS-CoV-2-anti-S protein RBD LFA and ELISA assessed IgM and IgG responses. Structural analysis identified host salivary molecules analogous to SARS-CoV-2-N-antigen. At time of enrollment (baseline, BL), LFA-detected N-antigen in 86% of TW and was immunoblot-confirmed. However, only 3/17 were saliva/TW qPCR+ . Sixty percent of saliva and 83% of TW demonstrated persistent N-antigen at 4 weeks. N-antigen LFA signal in three anti-spike sero-negative participants suggested potential cross-detection of 4 structurally analogous salivary RNA binding proteins (alignment 19-29aa, RMSD 1-1.5 Angstroms). At enrollment, symptomatic participants demonstrated replication-associated sgRNA junctions, were IgG+ (94%/100% in saliva/TW), and IgM+ (63%/54%). At 4 weeks, SARS-CoV-2 IgG (100%/83%) and IgM (80%/67%) persisted. Oral and serum IgG correlated 100% with NP+ PCR status. Cough and fatigue severity (p = 0.010 and 0.018 respectively), and presence of weakness, nausea, and composite upper respiratory symptoms (p = 0.037, 0.005, and 0.017, respectively) were negatively associated with saliva IgM but not TW or serum IgM. Throat wash IgM levels were higher in women compared to men, although the association did not reach statistical significance (median: 290 (female) versus 0.697, p = 0.056). Important to transmission and disease course, oral viral replication and persistence showed clear relationships with select symptoms and early oral IgM responses during early infection. N-antigen cross-reactivity may reflect mimicry of structurally analogous host proteins.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients
    Plume, Janis
    Galvanovskis, Artis
    Smite, Sindija
    Romanchikova, Nadezhda
    Zayakin, Pawel
    Line, Aija
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [2] Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients
    Jānis Plūme
    Artis Galvanovskis
    Sindija Šmite
    Nadezhda Romanchikova
    Pawel Zayakin
    Aija Linē
    Journal of Translational Medicine, 20
  • [3] SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity
    Phipps, William S.
    SoRelle, Jeffrey A.
    Li, Quan-Zhen
    Mahimainathan, Lenin
    Araj, Ellen
    Markantonis, John
    Lacelle, Chantale
    Balani, Jyoti
    Parikh, Hiren
    Solow, E. Blair
    Karp, David R.
    Sarode, Ravi
    Muthukumar, Alagarraju
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 (04) : 459 - 465
  • [4] Antibody Responses to SARS-CoV-2 in Children With COVID-19
    Han, Mi Seon
    Um, Jihye
    Lee, Eun Joo
    Kim, Kyung Min
    Chang, Sung Hee
    Lee, Hyunju
    Kim, Ye Kyung
    Choi, Youn Young
    Cho, Eun Young
    Kim, Dong Hyun
    Choi, Jae Hong
    Lee, Jina
    Kim, Misuk
    Chung, Ki-Hyun
    Min, Hye Sook
    Choe, Young June
    Lim, Dong-Gyun
    Park, Jun-Sun
    Choi, Eun Hwa
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2022, 11 (06) : 267 - 273
  • [5] Antibody responses to SARS-CoV-2 in patients with COVID-19
    Long, Quan-Xin
    Liu, Bai-Zhong
    Deng, Hai-Jun
    Wu, Gui-Cheng
    Deng, Kun
    Chen, Yao-Kai
    Liao, Pu
    Qiu, Jing-Fu
    Lin, Yong
    Cai, Xue-Fei
    Wang, De-Qiang
    Hu, Yuan
    Ren, Ji-Hua
    Tang, Ni
    Xu, Yin-Yin
    Yu, Li-Hua
    Mo, Zhan
    Gong, Fang
    Zhang, Xiao-Li
    Tian, Wen-Guang
    Hu, Li
    Zhang, Xian-Xiang
    Xiang, Jiang-Lin
    Du, Hong-Xin
    Liu, Hua-Wen
    Lang, Chun-Hui
    Luo, Xiao-He
    Wu, Shao-Bo
    Cui, Xiao-Ping
    Zhou, Zheng
    Zhu, Man-Man
    Wang, Jing
    Xue, Cheng-Jun
    Li, Xiao-Feng
    Wang, Li
    Li, Zhi-Jie
    Wang, Kun
    Niu, Chang-Chun
    Yang, Qing-Jun
    Tang, Xiao-Jun
    Zhang, Yong
    Liu, Xia-Mao
    Li, Jin-Jing
    Zhang, De-Chun
    Zhang, Fan
    Liu, Ping
    Yuan, Jun
    Li, Qin
    Hu, Jie-Li
    Chen, Juan
    NATURE MEDICINE, 2020, 26 (06) : 845 - +
  • [6] Antibody responses to SARS-CoV-2 in patients with COVID-19
    Quan-Xin Long
    Bai-Zhong Liu
    Hai-Jun Deng
    Gui-Cheng Wu
    Kun Deng
    Yao-Kai Chen
    Pu Liao
    Jing-Fu Qiu
    Yong Lin
    Xue-Fei Cai
    De-Qiang Wang
    Yuan Hu
    Ji-Hua Ren
    Ni Tang
    Yin-Yin Xu
    Li-Hua Yu
    Zhan Mo
    Fang Gong
    Xiao-Li Zhang
    Wen-Guang Tian
    Li Hu
    Xian-Xiang Zhang
    Jiang-Lin Xiang
    Hong-Xin Du
    Hua-Wen Liu
    Chun-Hui Lang
    Xiao-He Luo
    Shao-Bo Wu
    Xiao-Ping Cui
    Zheng Zhou
    Man-Man Zhu
    Jing Wang
    Cheng-Jun Xue
    Xiao-Feng Li
    Li Wang
    Zhi-Jie Li
    Kun Wang
    Chang-Chun Niu
    Qing-Jun Yang
    Xiao-Jun Tang
    Yong Zhang
    Xia-Mao Liu
    Jin-Jing Li
    De-Chun Zhang
    Fan Zhang
    Ping Liu
    Jun Yuan
    Qin Li
    Jie-Li Hu
    Juan Chen
    Nature Medicine, 2020, 26 : 845 - 848
  • [7] SARS-CoV-2 and COVID-19
    Sheng, Wang-Huei
    Ko, Wen-Chien
    Huang, Yhu-Chering
    Hsueh, Po-Ren
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 363 - 364
  • [8] Rehabilitation with coronavirus disease with SARS-CoV-2 (COVID-19)
    Platz, Thomas
    Dewey, Stefan
    Koellner, Volker
    Schlitt, Axel
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (15) : 981 - 988
  • [9] Rehabilitation with coronavirus disease with SARS-CoV-2 (COVID-19)
    Platz, Thomas
    Dewey, Stefan
    Koellner, Volker
    Schlitt, Axel
    REHABILITATION, 2022, 61 (04) : 297 - 310
  • [10] Airborne transmission of SARS-CoV-2 disease (COVID-19)
    Parvez, Mohammad K.
    Parveen, Shama
    FUTURE VIROLOGY, 2022, 17 (05) : 261 - 264